Sunshine Biopharma (SBFM) Announces Reverse Stock Split

Sunshine Biopharma, Inc. (NASDAQ: SBFM) (the "Company" or "Sunshine Biopharma"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, announced today a one for twenty reverse split of its common stock, effective at market open on August 8, 2024. The reverse stock split was undertaken to regain compliance with Nasdaq's minimum bid price requirement for continued listing.

You May Also Be Interested In

• Uber and Baidu launch driverless robotaxi service in Dubai
• BRT Apartments (BRT) Reiterated at Market Outperform by Citizens as Fundamentals Improve
• Piper Sandler Starts Madison Square Garden Entertainment (MSGE) at Neutral